Portfolio details

Sylvain Chrétien
Founded in 2007, Pediapharm is the first and only pediatric specialty pharmaceutical company in Canada.

The company's mission is loud and clear: become Canada's leading pediatric specialty pharma company by seeking and delivering the highest quality, new and existing therapeutic medicines to improve the health and assure the wellbeing of Canadian children.

Due to its well established commercial infrastructure combined with a seasoned management team, 5 innovative products have reached with success the Canadian market including the most recent one called NYDA: a revolutionary product that not only kills the lice but also its nits. In 2009, Pediapharm had launched with tremendous success EpiCeram: a new innovation for the treatment of eczema (atopic dermatitis). The future looks very promising as Pediapharm is on its way to conclude other agreements which will add 6 NEW products in its portfolio by 2012.

The investments by FIER Innovation Durable s.e.c. and FIER Innovation Durable s.e.c. will help the company to continue with its development and commercialisation.

For informations:
Sylvain Chrétien, Président
1 Place du Commerce #225
Verdun, QC H3E 1A2
(514) 762-2626

Sitemap © All rights reserved - Corposana Capital